EP1107797A4 - HYPOXIA-REGULATED GENES. - Google Patents

HYPOXIA-REGULATED GENES.

Info

Publication number
EP1107797A4
EP1107797A4 EP99945522A EP99945522A EP1107797A4 EP 1107797 A4 EP1107797 A4 EP 1107797A4 EP 99945522 A EP99945522 A EP 99945522A EP 99945522 A EP99945522 A EP 99945522A EP 1107797 A4 EP1107797 A4 EP 1107797A4
Authority
EP
European Patent Office
Prior art keywords
regulated genes
hypoxia regulated
hypoxia
genes
regulated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99945522A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1107797A2 (en
Inventor
Elena Feinstein
Paz Einat
Rami Skaliter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quark Pharmaceuticals Inc
Original Assignee
Quark Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quark Biotech Inc filed Critical Quark Biotech Inc
Publication of EP1107797A2 publication Critical patent/EP1107797A2/en
Publication of EP1107797A4 publication Critical patent/EP1107797A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Vascular Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP99945522A 1998-08-27 1999-08-27 HYPOXIA-REGULATED GENES. Withdrawn EP1107797A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US9815898P 1998-08-27 1998-08-27
US98158P 1998-08-27
US13268499P 1999-05-05 1999-05-05
US132684P 1999-05-05
PCT/US1999/020393 WO2000012139A1 (en) 1998-08-27 1999-08-27 Hypoxia regulated genes

Publications (2)

Publication Number Publication Date
EP1107797A2 EP1107797A2 (en) 2001-06-20
EP1107797A4 true EP1107797A4 (en) 2002-10-16

Family

ID=26794273

Family Applications (2)

Application Number Title Priority Date Filing Date
EP99945522A Withdrawn EP1107797A4 (en) 1998-08-27 1999-08-27 HYPOXIA-REGULATED GENES.
EP99945523A Withdrawn EP1115733A4 (en) 1998-08-27 1999-08-27 SEQUENCE CHARACTERISTICS OF THE HYPOXIA-REGULATED GENE TRANSCRIPTION

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP99945523A Withdrawn EP1115733A4 (en) 1998-08-27 1999-08-27 SEQUENCE CHARACTERISTICS OF THE HYPOXIA-REGULATED GENE TRANSCRIPTION

Country Status (6)

Country Link
EP (2) EP1107797A4 (enExample)
JP (2) JP2002525081A (enExample)
AU (1) AU5810999A (enExample)
CA (2) CA2341705A1 (enExample)
IL (2) IL141666A0 (enExample)
WO (2) WO2000012525A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4175662B2 (ja) 1996-01-08 2008-11-05 インパルス ダイナミクス エヌ．ヴイ． 電気的筋肉制御装置
US9289618B1 (en) 1996-01-08 2016-03-22 Impulse Dynamics Nv Electrical muscle controller
US9713723B2 (en) 1996-01-11 2017-07-25 Impulse Dynamics Nv Signal delivery through the right ventricular septum
EP1002862A1 (en) * 1998-11-12 2000-05-24 Nitsch, Roger M., Prof. Dr. Methods of diagnosing or treating neurological diseases
WO2006073671A1 (en) 2004-12-09 2006-07-13 Impulse Dynamics Nv Protein activity modification
US9101765B2 (en) 1999-03-05 2015-08-11 Metacure Limited Non-immediate effects of therapy
IL155951A0 (en) * 2000-11-28 2003-12-23 Wyeth Corp Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
WO2002103017A1 (en) * 2001-05-31 2002-12-27 Chiba-Prefecture Nucleic acids isolated in neuroblastoma
WO2003000012A2 (en) 2001-06-21 2003-01-03 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer
JP2006515747A (ja) * 2002-11-01 2006-06-08 ジェネンテック・インコーポレーテッド 免疫関連疾患の治療のための組成物と方法
US11439815B2 (en) 2003-03-10 2022-09-13 Impulse Dynamics Nv Protein activity modification
WO2005041857A2 (en) * 2003-10-07 2005-05-12 Quark Biotech, Inc. Bone morphogenetic protein (bmp) 2a and uses thereof
US11779768B2 (en) 2004-03-10 2023-10-10 Impulse Dynamics Nv Protein activity modification
EP1898991B1 (en) 2005-05-04 2016-06-29 Impulse Dynamics NV Protein activity modification
WO2011092710A2 (en) 2010-02-01 2011-08-04 Metacure Limited Gastrointestinal electrical therapy
JP2011206049A (ja) * 2010-03-08 2011-10-20 Sumio Sugano 壊死マーカー及びその用途
JP2013220090A (ja) * 2012-04-19 2013-10-28 Tohoku Univ 眼疾患治療に使用する薬剤スクリーニング方法
EP3548005A4 (en) 2016-11-29 2020-06-17 Puretech Health LLC Exosomes for delivery of therapeutic agents

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1002862A1 (en) * 1998-11-12 2000-05-24 Nitsch, Roger M., Prof. Dr. Methods of diagnosing or treating neurological diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2240492A (en) 1991-06-20 1993-01-25 United States Of America, As Represented By The Secretary, Department Of Health And Human Services, The Sequences characteristic of human gene transcription product
US5731294A (en) * 1993-07-27 1998-03-24 Hybridon, Inc. Inhibition of neovasularization using VEGF-specific oligonucleotides
US5882914A (en) * 1995-06-06 1999-03-16 The Johns Hopkins University School Of Medicine Nucleic acids encoding the hypoxia inducible factor-1
WO1998039448A2 (en) * 1997-03-07 1998-09-11 Human Genome Sciences, Inc. 186 human secreted proteins

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1002862A1 (en) * 1998-11-12 2000-05-24 Nitsch, Roger M., Prof. Dr. Methods of diagnosing or treating neurological diseases

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NOMURA N ET AL: "PREDICTION OF THE CODING SEQUENCES OF UNIDENTIFIED HUMAN GENES, I. THE CODING SEQUENCES OF 40 NEW GENES (KIAA0001-KIAA0040) DEDUCED BYANALYSIS OF RANDOMLY SAMPLED CDNA CLONES FROM HUMAN IMMATURE MYELOID CELL LINE KG-1 (SUPPLEMENT)", DNA RESEARCH, UNIVERSAL ACADEMY PRESS, JP, vol. 1, no. 1, SUPPL 47, 1997, pages 47 - 56, XP002099608, ISSN: 1340-2838 *

Also Published As

Publication number Publication date
IL141660A0 (en) 2002-03-10
JP2002523072A (ja) 2002-07-30
CA2341518A1 (en) 2000-03-09
JP2002525081A (ja) 2002-08-13
EP1115733A1 (en) 2001-07-18
WO2000012139A1 (en) 2000-03-09
EP1115733A4 (en) 2003-01-22
EP1107797A2 (en) 2001-06-20
WO2000012139B1 (en) 2000-05-04
AU5810999A (en) 2000-03-21
WO2000012525A1 (en) 2000-03-09
CA2341705A1 (en) 2000-03-09
IL141666A0 (en) 2002-03-10

Similar Documents

Publication Publication Date Title
ZA983487B (en) Leukemia associated genes
ZA989538B (en) Single mould-half alignment
TW509009U (en) Buckle
TW504971U (en) Buckle
AU133942S (en) Channel member
IL141666A0 (en) Hypoxia regulated genes
EP1018307A4 (en) BUCKLE
AU6417799A (en) Matrix-remodeling genes
EP1038957A4 (en) GENE TSA305
TW432944U (en) Buckle
GB2338890B (en) Improved backpack
GB9804376D0 (en) Clipboard
TW468395U (en) Buckle
TW441255U (en) Buckle
EP1092021A4 (en) NPY-Y7 RECEPTOR GENE
GB9824010D0 (en) Reins
GB9724828D0 (en) Gene
GB9825899D0 (en) Stationery
GB9813027D0 (en) GSH-I & GSH-11 Genes
GB2306135B (en) Stationery sets
CA80420S (en) Planter
HU1281U (en) Multi purpose shoe-last
GB9819721D0 (en) Novel gene
GB9817566D0 (en) Gene
GB9809753D0 (en) Gene

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010327

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20020830

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 48/00 A, 7C 07H 21/04 B, 7C 12N 9/02 B, 7C 07K 14/47 B

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040302